Official guideline for cost-effectiveness evaluation
- Guideline for cost-effectiveness evaluation in Japan (second edition) [Japanese]
- Guideline for cost-effectiveness evaluation in Japan (second edition) [English]
- PRISMA statement (referred by chapter 5 of the guideline)
Notification
- Cost-effectiveness evaluation of medicines, medical devices and cellular and tissue-based products [in Japanese] (February 14th 2024)
- Listing of medicines to National Health Insurance [in Japanese] (February 14th 2024)
- Drug pricing system [in Japanese] (February 14th 2024)
- Listing of medical devices to National Health Insurance [in Japanese] (February 14th 2024)
- Pricing system of medical devices [in Japanese] (February 14th 2024)
Reporting format
- Reporting format for manufacture's submission [in Japanese]
- Reporting format for manufacture's submission [in Japanese]
- Disclosure policy [in Japanese]
Preliminary consultation
- Preliminary Consultation in Cost-Effectiveness Evaluation of Medicines and Medical Devices [in Japanese]
- Preliminary Consultation in Cost-Effectiveness Evaluation of Medicines and Medical Devices [in Japanese, Word format]
Cost-effectiveness evaluation system in Japan
- Overview of cost-effectiveness evaluation system in Japan [in Japanese]
- Overview of cost-effectiveness evaluation system in Japan [in English]
-
Application of economic evaluation of pharmaceuticals and medical devices in Japan
Fukuda T and Shiroiwa T. Application of economic evaluation of pharmaceuticals and medical devices in Japan. J. Natl. Inst. Public Health. 2019;8(1):27-33.
Other related documents
-
Explanation on Guideline for cost-effectiveness evaluation in Japan (first edition)
Shiroiwa T, Fukuda T, Ikeda S, et al. Development of an Official Guideline for the Economic Evaluation of Drugs/Medical Devices in Japan. Value Health. 2017;20(3):372-378.
-
Explanation on trial implementation of cost-effectiveness evaluation in Japan
Shiroiwa T, Fukuda T, Ikeda S, Takura T. New decision-making processes for the pricing of health technologies in Japan: The FY 2016/2017 pilot phase for the introduction of economic evaluations. Health Policy. 2017 ;121(8):836-841.